Consolidated Balance Sheets - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Current
Cash and cash equivalents (note 2)	$ 143	$ 175
Short-term Investments	86	62
Accounts Receivable, after Allowance for Credit Loss, Current	148	199
Other receivables (note 3)	21	21
Income taxes receivable	3	4
Other current assets (note 3)	57	47
Assets, Current, Total	458	508
Restricted cash and cash equivalents (note 2)	17	25
Long-term investments (note 2)	37	36
Other long-term assets (note 3)	59	57
Operating Lease, Right-of-Use Asset	27	32
Property, plant and equipment, net (note 3)	19	21
Intangible assets, net (note 3)	145	154
Goodwill (note 3)	561	562
Assets	1,323	1,395
Current
Accounts payable	6	17
Accrued liabilities (note 3)	112	117
Income taxes payable (note 4)	29	28
Deferred revenue, current (note 10)	174	194
Total current liabilities	321	356
Deferred revenue, non-current (note 10)	32	28
Operating lease liabilities	33	38
Other long-term liabilities	1	3
Long-term notes (note 5)	194	194
Total liabilities	581	619
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 590,171,424 voting common shares (February 29, 2024 - 589,232,539)	2,957	2,948
Deficit	(2,200)	(2,158)
Accumulated other comprehensive loss (note 8)	(15)	(14)
Total shareholders' equity	742	776
Total liabilities and shareholders' equity	$ 1,323	$ 1,395
Common issued (in shares)	590,171,424	589,232,539
Common outstanding (in shares)	590,171,424	589,232,539